Finance

Results: 13537-13548 of 41734

PR Newswire associated0

Dun & Bradstreet Global Survey of 10,000 Executives Uncovers Intensifying Strategic Risks Across Supply Chains, Trade and Investment Flows

PR Newswire associated0

Arab Palestinian Investment Company (APIC) Issues New Corporate Bonds Through Three Tranches Denominated in US Dollars, Jordanian Dinars and Euros with a Total Nominal Value of USD 120 Million

PR Newswire associated0

Ben's Original™ Reaffirms Its Mission to Provide Simple, Tasty Meals That Bring People Together Through New "Keep It Original" Global Brand Platform

PR Newswire associated0

NYSE Content advisory: Pre-Market update + Trump announces new tariffs on 14 countries

Business Wire associated0

Kobo Resources Launches Limited Edition Jersey to Support Village Communities Through Kobo Cup CSR Initiative

Champions Oncology Launches Radiopharmaceutical Services Platform, Expands Isotope License, and Screens More Than 30 PDX Models

Allegion Expands Access Solutions Portfolio with Innovative Waitwhile Software Platform

Heng Qin® is the first and only drug approved to treat DED associated with MGD and will be available to patients in China in the coming months.

Breakthrough in Ophthalmology! Hengrui’s Heng Qin® (Perfluorohexyloctane Eye Drops) Approved as First Treatment for Dry Eye Disease Associated with MGD

Vanderbilt Selects Parse Biosciences GigaLab to Generate Atlas of Early Neutralizing Antibodies to Measles, Mumps, and Rubella

Beacon Therapeutics completes enrollment in registrational Phase 2/3 VISTA trial of laru-zova for patients with XLRP

ViaLase Announces Strategic Leadership Transitions to Support Commercial Growth

Beacon Therapeutics completes enrollment in registrational Phase 2/3 VISTA trial of laru-zova for patients with XLRP